Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

interferon beta-1b 0.3 MG Injection [Betaseron]

Known as: INTERFERON BETA-1B 0.3MG/VIL (BETASERON), INTERFERON BETA-1B,RECOMBINANT 0.3MG/VIL (BETASERON), Betaseron 0.3 MG Injection 
National Institutes of Health

Related topics

Related topics

10 relations
Albumin Human, USPBetaseronDrug AllergyInjection
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors
IntroductionPatients with multiple sclerosis (MS) generally undergo long-term treatment with disease-modifying therapies (DMTs… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2013
Highly Cited
2013
Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity.
Interferon-β (IFN-β) products have been used for many years in the treatment of multiple sclerosis and include recombinant IFN… 
2012
2012
Disease-modifying drugs for multiple sclerosis and JC virus expression
Natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis (MS) occurred in two individuals also… 
  • table 1
  • table 2
  • table 3
  • table 4
2012
2012
Spotlight on Interferon-β-1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
Interferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high-frequency… 
2011
2011
Evaluation of soluble HLA-G as a biomarker for multiple sclerosis
Human leukocyte antigen G (HLA-G) is a nonclassical HLA class I antigen that stands out for its immune regulatory properties… 
  • figure 1
2011
2011
Dianas farmacológicas en la esclerosis múltiple
La esclerosis multiple es la enfermedad inflamatoria, desmielinizante y neurodegenerativa cronica mas frecuente en jovenes… 
Highly Cited
2005
Highly Cited
2005
Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients
Abstract Objectives : To determine whether a low fat diet supplemented with ω -3 positively affects quality of life (QOL) in… 
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Review
2004
Review
2004
The pros and cons of early treatment of relapsing forms of multiple sclerosis
Abstract.Cerebral axonal damage and brain atrophy begin at the earliest stages of multiple sclerosis (MS). Progressive neuronal… 
  • table 1
  • table 2
  • figure 1
2004
2004
Interferon-β-1b
SummaryAbstractInterferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high… 
1986
1986
The isolation of human beta-interferon receptor by wheat germ lectin affinity and immunosorbent column chromatographies.
Radioiodinated human beta-interferon-Ser 17 (Betaseron) was reversibly cross-linked to Daudi cells by dithiobis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE